Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	192.05B +9.6%
Revenue (ttm)	255.21B -1.7%
Net Income	13.60B -41.9%
EPS	857.41 -44.0%
Shares Out	18.48M
PE Ratio	12.12
Forward PE	10.70
Dividend	300.00 (2.85%)
Ex-Dividend Date	Dec 29, 2025

Volume	30,231
Average Volume	27,032
Open	10,540
Previous Close	10,530
Day's Range	10,250 - 10,690
52-Week Range	9,990 - 13,210
Beta	0.13
RSI	49.09
Earnings Date	Apr 30, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 601
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2025, Whan In Pharm's revenue was 255.21 billion, a decrease of -1.69% compared to the previous year's 259.60 billion. Earnings were 13.60 billion, a decrease of -41.85%.